• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者肺动脉高压发生及死亡的相关因素

Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients.

作者信息

Kim J S, Kim D, Joo Y B, Won S, Lee J, Shin J, Bae S-C

机构信息

1 Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.

2 Department of Rheumatology, St Vincent's Hospital, Catholic University of Korea, Suwon, Republic of Korea.

出版信息

Lupus. 2018 Oct;27(11):1769-1777. doi: 10.1177/0961203318788163. Epub 2018 Jul 20.

DOI:10.1177/0961203318788163
PMID:30028258
Abstract

Objectives This study aims to identify the factors associated with the development and mortality of pulmonary hypertension (PH) in systemic lupus erythematosus (SLE) patients. Methods We conducted a prospective study of SLE patients in a single tertiary center. PH was defined as a systolic pulmonary arterial pressure ≥30 mmHg on transthoracic echocardiography. We assessed potential associated factors contributing to the development and mortality of PH in SLE patients. Results Of 1110 patients with SLE, 48 patients were identified to have PH. Multivariable analysis indicated that pleuritis or pericarditis (odds ratio (OR) = 4.62), anti-RNP antibody (OR = 2.42), interstitial lung disease (ILD) (OR = 8.34) and cerebro-cardiovascular disease (OR = 13.37) were independently associated with the development of PH in SLE. Subgroup analysis among patients with PH demonstrated that there were no statistically significant factors associated with PH mortality in SLE. Conclusions The prevalence of PH was 4.3% in our cohort. There were significant associations with pleuritis or pericarditis, anti-RNP antibody, ILD, and cerebro-cardiovascular disease in SLE, which may contribute to the development of PH. However, there were no statistically significant factors associated with PH mortality in SLE.

摘要

目的 本研究旨在确定系统性红斑狼疮(SLE)患者肺动脉高压(PH)发生及死亡的相关因素。方法 我们在一个单一的三级中心对SLE患者进行了一项前瞻性研究。PH定义为经胸超声心动图测得的收缩期肺动脉压≥30 mmHg。我们评估了导致SLE患者PH发生及死亡的潜在相关因素。结果 在1110例SLE患者中,48例被确定患有PH。多变量分析表明,胸膜炎或心包炎(比值比(OR)=4.62)、抗RNP抗体(OR =2.42)、间质性肺疾病(ILD)(OR =8.34)和心脑血管疾病(OR =13.37)与SLE患者PH的发生独立相关。PH患者的亚组分析表明,SLE中与PH死亡率相关的因素无统计学意义。结论 在我们的队列中,PH的患病率为4.3%。SLE中胸膜炎或心包炎、抗RNP抗体、ILD和心脑血管疾病之间存在显著关联,这可能导致PH的发生。然而,SLE中与PH死亡率相关的因素无统计学意义。

相似文献

1
Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients.系统性红斑狼疮患者肺动脉高压发生及死亡的相关因素
Lupus. 2018 Oct;27(11):1769-1777. doi: 10.1177/0961203318788163. Epub 2018 Jul 20.
2
Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.中国系统性红斑狼疮治疗与研究协作组(CSTAR)注册研究:二、中国系统性红斑狼疮患者肺动脉高压的患病率及危险因素
Lupus. 2014 Sep;23(10):1085-91. doi: 10.1177/0961203314527366. Epub 2014 Mar 20.
3
Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.系统性红斑狼疮中的肺动脉高压:患者生存的独立预测因素。
Korean J Intern Med. 2015 Mar;30(2):232-41. doi: 10.3904/kjim.2015.30.2.232. Epub 2015 Feb 27.
4
Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.系统性红斑狼疮患者及特发性肺动脉高压患者的肺动脉高压临床特征
Clin Rheumatol. 2006 Nov;25(6):866-72. doi: 10.1007/s10067-006-0206-5. Epub 2006 Feb 22.
5
Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.通过超声心动图评估结缔组织病相关肺动脉高压时确定右心导管检查的必要性。
Int J Rheum Dis. 2016 Jan;19(1):65-73. doi: 10.1111/1756-185X.12769. Epub 2015 Oct 7.
6
High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.系统性红斑狼疮患者体内的高尿酸水平与肺动脉高压有关。
Int J Rheum Dis. 2015 Jun;18(5):524-32. doi: 10.1111/1756-185X.12262. Epub 2014 Jan 16.
7
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.基于 CSTAR-PAH 研究的系统性红斑狼疮相关肺动脉高压:基线特征和危险因素。
Int J Rheum Dis. 2019 May;22(5):921-928. doi: 10.1111/1756-185X.13478. Epub 2019 Feb 11.
8
Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients.系统性红斑狼疮患者收缩期肺动脉压的无创评估:93 例回顾性分析。
Clin Exp Rheumatol. 2010 Nov-Dec;28(6):836-41. Epub 2011 Jan 3.
9
Pulmonary hypertension in systemic lupus erythematosus.系统性红斑狼疮中的肺动脉高压。
J Rheumatol. 1989 Jul;16(7):918-25.
10
Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.与中国系统性红斑狼疮住院患者肺动脉高压相关的特征。
Clin Rheumatol. 2018 Jun;37(6):1547-1553. doi: 10.1007/s10067-018-4056-8. Epub 2018 Mar 8.

引用本文的文献

1
Risk Factors for Adverse Outcomes in Connective Tissue Disease-Associated Pulmonary Hypertension.结缔组织病相关肺动脉高压不良结局的危险因素
Rev Cardiovasc Med. 2025 Mar 17;26(3):26877. doi: 10.31083/RCM26877. eCollection 2025 Mar.
2
Epidemiology of systemic lupus erythematosus in Korea.韩国系统性红斑狼疮的流行病学
J Rheum Dis. 2023 Oct 1;30(4):211-219. doi: 10.4078/jrd.2023.0037. Epub 2023 Sep 11.
3
Survival and prognosis analysis of systemic lupus erythematosus patients with pulmonary hypertension: A systematic review and meta-analysis.
系统性红斑狼疮合并肺动脉高压患者的生存和预后分析:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Sep 8;102(36):e34947. doi: 10.1097/MD.0000000000034947.
4
Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.基于共识聚类和风险预测模型的系统性红斑狼疮相关性肺动脉高压的临床特征和预后。
Arthritis Res Ther. 2023 Aug 23;25(1):155. doi: 10.1186/s13075-023-03139-y.
5
Update on the Treatment of Pulmonary Arterial Hypertension.肺动脉高压治疗进展。
Arq Bras Cardiol. 2021 Oct;117(4):750-764. doi: 10.36660/abc.20200702.
6
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Southern Taiwan: A Single-Center 10-Year Longitudinal Observation Cohort.台湾南部结缔组织病相关肺动脉高压:单中心10年纵向观察队列
Healthcare (Basel). 2021 May 20;9(5):615. doi: 10.3390/healthcare9050615.
7
Pulmonary Involvement in Children With Systemic Lupus Erythematosus.系统性红斑狼疮患儿的肺部受累情况
Front Pediatr. 2021 Feb 2;8:617137. doi: 10.3389/fped.2020.617137. eCollection 2020.
8
Autoantibody clustering of lupus-associated pulmonary hypertension.狼疮相关肺动脉高压的自身抗体聚集
Lupus Sci Med. 2019 Dec 2;6(1):e000356. doi: 10.1136/lupus-2019-000356. eCollection 2019.
9
Frequency and predictors of pulmonary hypertension in patients with Systemic Lupus Erythematosus.系统性红斑狼疮患者肺动脉高压的发生率及预测因素
Pak J Med Sci. 2019 Jan-Feb;35(1):86-89. doi: 10.12669/pjms.35.1.405.